Biotech Values

[drbio45]

Thus, even if another company can make the drug better or cheaper, they’ll have to cut a deal with MDCO unless they have their own set of clinical data.


I guess the point that I am trying to make is that mdco is not really much further away from getting the drug approved than anyone else. In fact they could start trials and have manufacturing problems and could fall behind a company with a better, easier process